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OmicsSeveral computational methods have been developed that integrate transcriptomic data with genome-scale
metabolic reconstructions to infer condition-speciﬁc system-wide intracellular metabolic ﬂux distributions. In
this mini-review, we describe each of these methods published to date with categorizing them based on four
different grouping criteria (requirement formultiple gene expression datasets as input, requirement for a thresh-
old to deﬁne a gene's high and low expression, requirement for a priori assumption of an appropriate objective
function, and validation of predicted ﬂuxes directly against measured intracellular ﬂuxes). Then, we recommend
which group of methods would be more suitable from a practical perspective.
© 2014 Kim and Lun. Published by Elsevier B.V. on behalf of the Research Network of Computational and Structural
Biotechnology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
2. Grouping criterion 1: requirement for multiple gene expression datasets as input . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3. Grouping criterion 2: requirement for a threshold to deﬁne a gene's high/low expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4. Grouping criterion 3: requirement for a priori assumption of an appropriate objective function . . . . . . . . . . . . . . . . . . . . . . . . . 63
5. Grouping criterion 4: validation of predicted ﬂuxes directly against measured intracellular ﬂuxes . . . . . . . . . . . . . . . . . . . . . . . . 63
6. Summary and outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 641. Introduction
Intracellular metabolic reactions provide a cell with basic biochemical
building blocks, energy, and a thermodynamically favorable environment
to sustain its life. Because of the large connectivity inherent to metabolic
networks via metabolites participating in multiple metabolic reactions,
determination of system-level changes in intracellular metabolic
ﬂuxes of organisms is important for understanding the fundamental
mechanisms of their metabolic responses to environmental or genetic
perturbations [1,2].
13C metabolic ﬂux analysis (13C-MFA) allows intracellular ﬂuxes
to be quantiﬁed experimentally. In this approach, cells are grown on
13C-labeled substrates until the cells are at both metabolic steady state
(i.e. when concentrations of metabolites remain stable over time) andnd Integrative Biology, Rutgers
4; fax: +1 856 225 6624.
lun@rutgers.edu (D.S. Lun).
. on behalf of the Research Network oisotopic steady state (i.e. when the isotope label is distributed through-
out the network, and all isotopomer fractions are constant over time).
Then the level of 13C enrichment in metabolites of the cells is measured
by mass spectrometry (MS) or nuclear magnetic resonance (NMR).
Intracellular ﬂux distribution is reconstituted from the 13C enrichment
patterns [3–8]. System-wide quantiﬁcation of intracellular metabolic
ﬂuxes using 13C-MFA, however, is challenging not only because of the
extensive instrumentation required but also because of the limited
number of ﬂuxes and conditions that can be experimentally measured.
Typically, 13C-MFA focuses on central carbon metabolism [7–10].
An alternativemethod that is widely used for system-level studies of
metabolism is a computational modeling approach called ﬂux balance
analysis (FBA). FBA predicts metabolic ﬂux distributions at steady
state by making use of in silico genome-scale metabolic models [11].
These genome-scale metabolic models are assembled and manually-
curated from annotated genome, biochemical, genetic, and cell pheno-
type data [11–13]. To use FBA, a genome-scale metabolic model is
converted into a m × n stoichiometric matrix, S, where the rows in Sf Computational and Structural Biotechnology. This is an open access article under the CC BY
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columns represent the n reactions (Fig. 1a). Each matrix element sij,
indicates a stoichiometric coefﬁcient, that is, the number of molecules
of the ith metabolite participating in the jth reaction. sij = 0 means
that the ith metabolite is not involved, and a positive or a negative sij
indicates that the ith metabolite is a product or a reactant of the jth re-
action, respectively. Under the steady state assumption, the metabolic
ﬂux distribution can be represented mathematically by S·v = 0,
where v is a column vector whose elements are the unknown reaction
rates (ﬂuxes) through each of the reactions of S (Fig. 1b). Since
genome-scalemetabolicmodels include all possiblemetabolic reactions
implied by the genome annotation regardless of whether the annotated
metabolic genes are expressed in a given environment, the resulting
system S·v=0, is in general underdetermined [14,15]. Thus, physiolog-
ically meaningful ﬂux solutions need to be narrowed down from all the
possible ﬂux distributions by imposing additional constraints on the
system and by optimizing certain objective functions when performing
FBA (Fig. 1c) [16]. The standard FBA involves solving the following lin-
ear optimization problem:
max f 0v
subject to Sv ¼ 0lb≤v≤ub
 ð1Þ
where v is a ﬂux vector representing the reaction rates of the n reactions
in the network, f is a coefﬁcient vector deﬁning the organism's objective
function, S is the stoichiometric matrix, and lb and ub are theminimum
and maximum reaction rates through each reaction in v.
If the complete regulatory structure of an organism were known, it
would be possible to produce context-speciﬁc constraints by computing
which cellular components may be expressed in a given condition.Fig. 1. Flux balance analysis (FBA). This ﬁgure illustrates how FBA works with an example o
reactions. (a) To use FBA, the network is converted into a stoichiometricmatrix, S, where the row
the reactions. Eachmatrix element sij, indicates a stoichiometric coefﬁcient, that is, the number o
metabolite is not involved, and a positive or a negative sij indicates that the ithmetabolite is a pr
the metabolic ﬂux distribution can be represented mathematically by S·v= 0, where v is a col
reactions of S.(c) Since the resulting system, S·v = 0, is usually underdetermined, physiolo
distributions by imposing additional constraints on the system (e.g. 0 ≤ v ≤ 2 in the ﬁgure) anHowever, the regulatory structure is unknown even for the relatively
simple and extensively-studied bacterium, Escherichia coli, partly due
to the lack of comprehensive transcription unit information andbecause
of the lack of information on the relationship between genotype and
phenotype [17].
Recent advances in omics technologies have enabled quantitative
monitoring of the abundance of biological molecules at various levels
in a high-throughput manner [18]. In the absence of complete informa-
tion on regulatory rules, omics data can be integrated with genome-
scale metabolic models to improve their predictive power [19,20]. For
this purpose, transcriptomic data, i.e. genome-wide mRNA expression
proﬁling data, is useful in some points compared to other omics plat-
forms. Fluxomics (i.e. 13C-MFA) is themost directmeasurement ofmet-
abolic phenotype, but has the disadvantages in that it is difﬁcult tomake
measurements and only a limited number of ﬂuxes can be determined
as mentioned above. Metabolomics can also be useful, but typically
ﬂuxes are more informative than metabolite concentrations them-
selves, and it is challenging to determine ﬂuxes from metabolite
concentrations partly because each metabolite participates in multiple
metabolic reactions. Similar to ﬂuxes, speciﬁc classes of metabolites
such as lipids or labile chemicals easily metabolized are still demanding
to measure [21,22]. Unlike the ﬁrst two omics data that cover a small
share of all reactions in a genome-scalemodel, transcriptomics and pro-
teomics are the platforms where a quantitative snapshot of molecular
species at system-level is currently possible [23]. However, proteomics
is a relatively immature technology compared to transcriptomics. The
accuracy with which protein concentrations can be determined is
much lower than that with which mRNA concentrations can be deter-
mined. On the other hand, RNA amount changes can be precisely mea-
sured in a highly automated process at low cost in comparison with the
amount of data gathered [24,25]. By integrating transcriptomics dataf the simple network below consisting of two metabolites, A and B, and three metabolic
s in S correspond to themetabolites of themetabolic network, and the columns represent
f molecules of the ithmetabolite participating in the jth reaction. sij=0means that the ith
oduct or a reactant of the jth reaction, respectively. (b) Under the steady state assumption,
umn vector whose elements are the unknown reaction rates (ﬂuxes) through each of the
gically meaningful ﬂux solutions need to be narrowed down from all the possible ﬂux
d by optimizing certain objective functions (e.g.Max v3 in the ﬁgure).
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metabolic ﬂuxes through a relatively simple and low-cost omics
technology. If other omics technology especially proteomics technology
becomes asmature (e.g. wide coverage at lower cost with less effort) as
that of transcriptomics, most of the methods introduced in this paper
could be applied to other omics data, too.
Not only do genome-scale models beneﬁt from transcriptomic data
in creating condition- and tissue-speciﬁc models, but transcriptomic
data itself can also beneﬁt by being integrated onto the models.
Although a large amount of transcriptomic data is continuously being
generated, gaining meaningful insight into the functioning of cellular
processes from mRNA levels is challenging because of the functional
layers in between the two, such as translation, post-translational modi-
ﬁcations, mRNA/protein degradation, and enzyme activity regulation by
effectors (inhibitors or activators) [14,23,26]. Genome-scale metabolic
models arewell-suited to inferringmetabolic phenotype from genotype
using transcriptomic data, since the models are comprehensive reposi-
tories of biochemical data for organisms that enable the description of
gene–protein–reaction relationships [13,19]. Whereas correlations be-
tween mRNA and ﬂuxes have been often found to be poor, approaches
taking into account for the large connectivity of metabolites inherent
to metabolic networks have been successful in linking gene expression
level to metabolites [2,27–29]. This implies that the consideration of
the metabolic network is essential to draw a predictive relation from
transcript abundances to ﬂuxes [23].
For these reasons, there have been previous studies to integrate
transcriptomic data with genome-scale metabolic models, and some
of these methods have been covered in recent reviews [12,14,18,
30–33]. However, most of these reviews broadly introduce methods in-
ferringmetabolic ﬂuxes from various kinds of omics data and are not fo-
cused speciﬁcally on transcriptomic data. In addition, some of the
reviews do not include the most recent methods since transcriptomic
data-driven metabolic modeling methods are being developed at a
fast pace [33]. In this mini-review, we focus on introducing methods
for integrating transcriptomic data in genome-scale metabolic models,
and we give a brief description of each one published to date. We ex-
cludemethods that requiremulti-omics datasets as input for an analysis
even if they use transcriptomic data, because multi-omics studies are
not common [34–37]. We categorize all methods that are covered in
this paper based on four different grouping criteria, and we evaluate
which group of methods is more suitable from a practical perspective.
Lastly, we discuss several limitations of existing methods that new
methods need to overcome.2. Grouping criterion 1: requirement for multiple gene expression
datasets as input
As the ﬁrst criterion, methods for estimating metabolic ﬂux from
transcriptomic data can be grouped by how many gene expression
datasets are required as input. There are two representative methods
that need multiple transcriptomic datasets measured under two or
more conditions for an analysis.
First, Probabilistic Regulation Of Metabolism (PROM) published in
2010 is a method that integrates regulatory and metabolic networks
[38]. It calculates the probability of a metabolic target gene being
expressed relative to the activity of its regulating transcription factor
from a large dataset of gene expression data, and the ﬂux maxima of
the metabolic reaction associated with the metabolic target gene is
constrained by a factor of this probability (Fig. 2a). It has several advan-
tages such as its ability to account for the presence of noise in the data,
and to differentiate between a strong transcriptional regulator and a
weak one. However, thismethod requires a large number of experimen-
tal datasets to calculate the probability of regulatory interactions be-
tween transcription factors and their target genes. It also requires a
priori knowledge on transcription factor–target gene pairs. In theoriginal paper, around 1300 microarrays and 2000 transcription
factor–target interactions were used for E. coli and Mycobacterium
tuberculosis.
Second, Metabolic Adjustment by Differential Expression (MADE)
published in 2011, was developed to overcome the issue of selecting a
subjective user-supplied threshold in deﬁning a gene's high and low ex-
pression states [39]. MADE creates a sequence of binary expression
states using several datasets for differential gene expression so as to
ﬁnd the model that most closely reproduces the observed expression
changes (Fig. 2b). The principle of this method is that if the activity of
a gene drastically changes from one condition to the other, the ﬂux
through the reaction controlled by that gene will change accordingly
[40]. Using this method, the authors examined the metabolic effects of
the transition from glucose- to glycerol-based growth in Saccharomyces
cerevisiae over the course of time. They showed that the binary expres-
sion state changes calculated by MADE matched 98.7% of the feasible
observed gene expression transitions (83.5% of all expression transi-
tions). They also showed that, accompanied by these expression state
changes, the ﬂux variability of the model was increased after the shift
to glycerol.
The other methods described below use a single gene expression
dataset for each experimental condition. One of the possible concerns
of using a single transcriptomic dataset may be the lack of proportional-
ity between transcript and ﬂux levels. Accounting for relative gene
expression changes frommultiple datasets as an indicator of the ﬂux re-
conﬁguration might seem to provide a more meaningful description.
However, a recent research paper shows that the methods that use rel-
ative expression levels does not necessarily givemore accurate ﬂux pre-
dictions [33]. Although bothmethods have advantages, the requirement
for multiple sets of input data such as transcription regulatory informa-
tion or different gene expression datasets to perform the analysis is
more onerous from a practical point of view.
3. Grouping criterion 2: requirement for a threshold to deﬁne a
gene's high/low expression
As the second criterion, methods can be grouped by whether they
use a user-supplied threshold. Some methods require discretization
(e.g. −1, 0, 1), binarization (e.g. 1, 0), or classiﬁcation (e.g. below/
above threshold) of gene expression measurement data according to
user-deﬁned arbitrary thresholds to distinguish active and inactive
states of the corresponding reactions. In addition to PROM, which is
mentioned in the previous section, the following three methods also
require thresholds.
An approach suggested byÅkesson et al. in 2004 is one of the earliest
methods to integrate genome-wide expression data into genome-scale
metabolic models [41]. In this method, the ﬂuxes of reactions whose
corresponding genes are not expressed are constrained as zero
(Fig. 2c). A probe set for a gene is considered absent if it is undetected
in all three replicates from independent cultures of the same condition.
Using this principle, they combined microarray measurements of gene
expression from chemostat and batch cultivations of S. cerevisiae with
a genome-scale model for yeast, iFF708 [42]. The computed metabolic
ﬂux distributions were compared to experimental values from 13C-
labeling experiments. The integration of expression data resulted in im-
proved predictions of metabolic behavior in batch culture. Due to the
Boolean nature of this method, failure in correctly detecting presence
of lowly expressed genes may give rise to erroneous predictions.
Gene Inactivity Moderated by Metabolism and Expression (GIMME)
introduced in 2008, creates a context-speciﬁc metabolic model that pre-
dicts the subset of reactions a cell is likely to use under particular condi-
tions using gene expression data [43]. This method consists of a two-
step procedure (Fig. 2d). First, the method ﬁnds a ﬂux distribution that
optimizes a given biological objective such as growth and/or ATP produc-
tion using FBA. Then, themethodminimizes the utilization of ‘inactive’ re-
actions whose corresponding mRNA transcript levels are below a given
Fig. 2. Representative methods currently available for integration of transcriptomic data in genome-scale metabolic models. (a)–(g) show how each method integrates gene expression
data onto the models. (a) PROM binarizes the gene expression data according to a user-supplied threshold. Then, it calculates the probability of a metabolic target gene being expressed
relative to the activity of its regulating transcription factor froma large dataset of gene expression data. Theﬂuxmaxima of themetabolic reaction associatedwith themetabolic target gene
is constrained bya factor of this probability. (b)MADE creates a sequenceof binary expression states using several datasets for differential gene expression so as toﬁnd themodel thatmost
closely reproduces the observed expression changes. (c) Åkesson'smethod is one of the earliest methods to integrate genome-wide expression data into genome-scalemetabolic models.
In this method, the ﬂuxes of reactions whose corresponding genes are not expressed are constrained as zero. (d) GIMME consists of a two-step procedure. First, the method ﬁnds a ﬂux
distribution that optimizes a given biological objective such as growth and/or ATP production using FBA. Then, the method minimizes the utilization of ‘inactive’ reactions whose corre-
sponding mRNA transcript levels are below a given threshold. (e) iMAT discretized gene expression data into tri-valued expression states, representing either low, moderate or high ex-
pression in the condition studied according to a user-speciﬁed threshold. Then, themethod ﬁnds an optimal metabolic ﬂux distribution that is the most consistent with the discrete gene
expression data bymaximizing the number of ﬂux-carrying reactions associatedwith highly expressed enzymes andminimizing the number of ﬂux-carrying reactions that correspond to
lowly-expressed enzymes. (f) E-Flux maps continuous gene expression levels into ﬂux bound constraints according to gene–protein–reaction (GPR) associations. It uses transcriptomic
data to set upper and lower bounds on metabolic ﬂuxes so that reactions associated with more highly expressed genes will be allowed to have higher absolute ﬂux values. (g) Dave
Lee's method uses transcriptomic data in the objective function. This method predicts intracellular metabolic ﬂuxes by minimizing the deviation between the ﬂux distribution and the
transcriptomic data. The deviation was calculated by the sum of absolute differences between ﬂuxes and corresponding gene expression data.
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consistent with the ﬂux distribution of the ﬁrst step, the method was
used to ﬁnd context-speciﬁc metabolic ﬂux distributions that best ﬁt
physiological data in E.coli and human skeletal muscle cells.
The integrative Metabolic Analysis Tool (iMAT) implements a meth-
od proposed by Shlomi et al. in 2008, which was developed for tissue-
speciﬁc modeling of metabolism in mammalian cells [44,45]. In this
method, gene expression data is discretized into tri-valued expression
states, representing either low, moderate or high expression in the con-
dition studied according to a user-speciﬁed threshold (Fig. 2e). Then,
iMAT ﬁnds an optimal metabolic ﬂux distribution that is the most con-
sistent with the discrete gene expression data bymaximizing the num-
ber ofﬂux-carrying reactions associatedwith highly expressed enzymes
and minimizing the number of ﬂux-carrying reactions that correspond
to lowly-expressed enzymes. This method does not require information
on biomass composition or metabolite exchange. By integrating
transcriptomic data with a global human metabolic model using this
method, they predicted tissue-speciﬁcmetabolic activity in ten different
tissues. A method called EXAMO (EXploration of Alternative Metabolic
Optima) is an extended version of iMAT that builds a context-speciﬁc
model [46].
Tailored gene expression using user-deﬁned thresholds may avoid
data normalization issues [33]. However, using arbitrary thresholds
may lead to subjective results that lose the ﬁne-grained information
for individual genes. This is because the speciﬁc threshold above
which the level of gene expression indicates physiological activeness
of corresponding reactionsmay vary across genes, conditions, or organ-
isms. The following two methods incorporate continuous gene expres-
sion values without using thresholds.
E-Flux (as a combination of ﬂux and expression) published in 2009
is a method that maps continuous gene expression levels into ﬂux
bound constraints according to gene–protein–reaction (GPR) associa-
tions [47,48]. It uses transcriptomic data to set upper and lower bounds
on metabolic ﬂuxes so that reactions associated with more highly
expressed genes will be allowed to have higher absolute ﬂux values
(Fig. 2f). The rationale behind E-ﬂux is that, given a limited translational
efﬁciency and a limited accumulation of enzyme over the time, the level
of mRNA can be used as an approximate upper bound on themaximum
amount of metabolic enzymes, and hence as a bound on reaction rates.
Using this method, the authors correctly predicted decreased mycolic
acid synthesis by seven of the eight known fatty acid inhibitors in
M. tuberculosis. In a follow-up study [48], they identiﬁed preferred car-
bon sources of E. coli that are not inﬂuenced by expression derived
constraints.
An approach suggested by Lee et al. uses transcriptomic data in the
objective function [49]. This method predicts intracellular metabolic
ﬂuxes by minimizing the deviation between the ﬂux distribution and
the transcriptomic data (Fig. 2g). The deviation was calculated by the
sum of absolute differences between ﬂuxes and corresponding gene ex-
pression data. The assumption behind this method is that enzymatic
transcript concentrations and metabolic ﬂuxes can be related to each
other, albeit in a complex manner, since the existence of a transcript is
necessary but not sufﬁcient for the presence or activity of its corre-
sponding enzyme [50]. They compared this method against FBA,
GIMME, and iMAT, showing a better accuracy in predicting experimen-
tally measured exometabolic ﬂux for S. cerevisiae cultures under two
growth conditions. FALCON (Flux Assignment with Least absolute
deviation ConvexObjectives andNormalization) is a recently published,
related method with improvements in time efﬁciency [51].
4. Grouping criterion 3: requirement for a priori assumption of an
appropriate objective function
The third feature that can distinguish the methods is whether a
method requires the a priori assumption of an appropriate biological
objective function.Except for the method of Lee et al. and iMAT, the other methods de-
scribed here need a priori knowledge of an appropriate objective func-
tion of the system such as biomass production rate. The biomass ﬂux
(i.e. the growth rate) is the most widely used objective function for
FBA optimization problems since it is commonly assumed that, under
given resources, efﬁcient growth of a certain microorganism compared
to its competitors is beneﬁcial for its survival from an evolutionary per-
spective [52,53]. Indeed, the assumption of biomass ﬂux maximization
in FBA has successfully predicted metabolic behavior of various organ-
isms in a number of studies [54,55]. Nevertheless, biomass ﬂux may
be unsuitable as an objective function for some organisms such as mi-
croorganisms with variable biomass composition, pathogens in dor-
mancy or in latent phase, or cells of a multi-cellular organism [56].
Thus, in practical applications, we sometimes need methods like the
method of Lee et al. and iMAT whose objective functions can be univer-
sally applied to a variety of organisms in cases where knowledge of the
biological objective function is uncertain.
5. Grouping criterion 4: validation of predicted ﬂuxes directly
against measured intracellular ﬂuxes
The last distinction among the methods is the utilization of mea-
sured intracellular ﬂuxes for the purpose of validation. Basically, the
output of the methods described here is predicted intracellular meta-
bolic ﬂux distribution. With the exception of the method of Åkesson
et al., none of these methods, however, have tested their predictive ac-
curacy against experimentally measured intracellular ﬂuxes. Lee et al.
did attempt to validate their predictions for the intracellular ﬂuxes indi-
rectly using exometabolomic data bymeasuring changes in the concen-
tration of extracellular metabolites. Nevertheless, considering that
detailed information on the underlying mechanisms of metabolic
responses is not accessible from extracellular physiological data, it
would be preferable to validate predictive accuracy using measured
intracellular ﬂuxes [57].
Table 1 summarizes the features of the presented methods with
regard to the four grouping criteria described so far.
6. Summary and outlook
Given its many advantages, the integration of transcriptomic data in
a genome-scale model is a promising method for predicting system-
level intracellular metabolic ﬂuxes. From a practical perspective, we
suggest that an ideal method satisﬁes all of the following criteria: a
method that needs a single gene expression dataset as input; that uti-
lizes continuous gene expression values without using arbitrary thresh-
olds; that can be used even when an appropriate objective function is
unknown; andwhose predictive accuracy is validated againstmeasured
intracellular ﬂuxes data.
Yet none of the surveyedmethods satisﬁes all of the practical condi-
tions. Lee'smethod seems to be themost practical method among them
in that it achieves three of the four criteria for a practically idealmethod.
An important limitation of the currently available methods including
Lee's method is that, except for the Åkesson's method, their predictive
accuracy has not been validated directly against experimentally mea-
sured intracellular ﬂuxes. Considering that the major purpose of devel-
oping these methods is to accurately predict context-speciﬁc
intracellular metabolic ﬂux distribution, it would be better if existing
or new methods prove how accurately they predict intracellular meta-
bolic distribution by comparing their results with in vivo intracellular
ﬂux data.
Importantly, the most practical method does not guarantee the best
or the most accurate method. The choice of themost appropriate meth-
od would depend on various factors such as biological systems of inter-
est, primary objective of study, and the availability of experimental data.
For instance, if we study fast-growing microorganisms such as E. coli
and S. cerevisiae of which the assumption of biomass ﬂux maximization
Table 1
Summary of the features of previous methods according to four grouping criteria described in this paper. Desirable features from a practical perspective are shaded in green.
Method Requirements for multiple  
transcriptomic datasets as input 
Requirement for a threshold 
to define a gene's high/low  
expression state
Requirement for a priori  
assumption of an appropriate  
objective function
Validation of predicted fluxes  
directly against measured  
intracellular fluxes  
E-Flux No No Yes No
Lee et al.  No No No No
Åkesson et al. No Yes Yes Yes (4 fluxes were 
used for validation)
GIMME No Yes Yes No
iMAT No Yes No No
PROM Yes Yes Yes No
MADE Yes No Yes No
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methods such as E-Flux and Åkesson'smethod that need a priori knowl-
edge of an appropriate objective function of the system would not be a
problem. However, in order to study a broad range of systems including
microorganisms with variable biomass composition, pathogens in dor-
mancy or in latent phase, or cells of a multi-cellular organism, the
methods such as Lee's method and iMAT whose objective functions
can be universally applied to a variety of conditions are more desirable
for such practical applications. In addition, if we focus on examining
clear changes in metabolic behavior of a system, and want to avoid
data normalization issues, using the methods that require binarized
gene expression data would be appropriate. However, if we need to
seemore ﬁnely grained information, and if it is hard to deﬁne the specif-
ic threshold above which the level of gene expression indicates physio-
logical activeness of corresponding reactions, using the methods which
incorporate continuous gene expression values would be useful. Lastly,
although PROM is sorted as an impractical method in Table 1 mainly
due to its requirements for a large number of experimental datasets
with regulatory information, PROM identiﬁed knock-out phenotypes
for E. coli andM. tuberculosis with accuracies as high as 95% [38]. Still,
as a recent research paper shows that the methods that use multiple
gene expression datasets does not necessarily give more accurate ﬂux
predictions [33], the requirement for a large amount of input data to
perform the analysis, which might make the job more onerous, could
be considered as another limitation of some of the existing methods
from a practical point of view.
In this paper, we introduced four different grouping criteria which
enable to categorize methods for integration of transcriptomic data in
genome-scale metabolic models. Based on these criteria, we suggested
features of a practically ideal method. Then, we discussed about which
group of the existing methods is more suitable to use for different
cases from a practical perspective. Considering that none of the sur-
veyedmethods satisﬁes all of the practical conditions, efforts to develop
a new method that overcomes the limitations of the existing methods
should be continued.
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